0001171843-16-008519.txt : 20160311 0001171843-16-008519.hdr.sgml : 20160311 20160311171408 ACCESSION NUMBER: 0001171843-16-008519 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160311 FILED AS OF DATE: 20160311 DATE AS OF CHANGE: 20160311 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Xenon Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001582313 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 980661854 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 - 3650 GILMORE WAY CITY: BURNABY STATE: A1 ZIP: V5G 48W BUSINESS PHONE: (604) 484-3300 MAIL ADDRESS: STREET 1: 200 - 3650 GILMORE WAY CITY: BURNABY STATE: A1 ZIP: V5G 48W REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PIMSTONE SIMON N. CENTRAL INDEX KEY: 0001620084 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36687 FILM NUMBER: 161501733 MAIL ADDRESS: STREET 1: 200 - 3650 GILMORE WAY CITY: BURNABY STATE: A1 ZIP: V5G4W8 4 1 formfour.xml OWNERSHIP DOCUMENT X0306 4 2016-03-11 0 0001582313 Xenon Pharmaceuticals Inc. XENE 0001620084 PIMSTONE SIMON N. C/O XENON PHARMACEUTICALS INC 200 - 3650 GILMORE WAY BURNABY A1 V5G 4W8 BRITISH COLUMBIA, CANADA 1 1 0 0 President & CEO Stock Option (Right to Buy) 7.49 2016-03-11 4 A 0 50000 0 A 2026-03-10 Common Shares 50000 50000 D Vesting 25% on January 1, 2017, and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month. /s/ Joanne Smartt, Attorney-in-fact 2016-03-11